Skip to main content
    T

    Tenet Healthcare Corporation (THC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $266.91
    -1.85 (-0.69%)

    Market Cap: $21.87B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    97%(38/39)
    Avg Surprise
    +102.28%
    Streak
    38 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$4.67
    Range$4.03 - $5.04
    20 analysts
    EPS RevisionsNo revisions (7d)
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$4.09+14.1%
    60d ago$4.67+0.1%
    30d ago$4.67+0.0%
    7d ago$4.670.0%
    Current$4.67
    Revenue Consensus
    $5.5B
    Range$5.4B - $5.9B
    18 analysts
    Period ending Dec 31, 2026
    EPS Consensus$8.12
    Range$7.56 - $8.55
    21 analysts
    Revenue Consensus
    $6.1B
    Range$5.7B - $7.9B
    20 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$8.12---
    Sep 26EST
    		-$4.67---
    Jun 26
    Reported Jul 22
    		$6.12$4.08+50.00%Beat+52.2%
    Mar 26
    Reported Apr 30
    		$4.82$4.17+15.59%Beat+10.6%
    Dec 25
    Reported Feb 11
    		$4.70$4.07+15.48%Beat+36.6%
    Sep 25
    Reported Oct 28
    		$3.70$3.35+10.45%Beat+26.3%
    Jun 25
    Reported Jul 22
    		$4.02$2.87+40.07%Beat+74.0%
    Mar 25
    Reported Apr 29
    		$4.36$3.13+39.30%Beat+35.4%
    Dec 24
    Reported Feb 12
    		$3.44$2.83+21.45%Beat+28.4%
    Sep 24
    Reported Oct 29
    		$2.93$2.37+23.63%Beat+103.5%
    Jun 24
    Reported Jul 24
    		$2.31$1.91+20.94%Beat+60.4%
    Mar 24
    Reported Apr 30
    		$3.22$1.44+123.61%Beat+126.8%
    Dec 23
    Reported Feb 8
    		$2.68$1.62+65.43%Beat+36.7%
    Sep 23
    Reported Oct 30
    		$1.44$1.20+20.00%Beat+0.0%
    Jun 23
    Reported Jul 31
    		$1.44$1.25+15.20%Beat-4.0%
    Mar 23
    Reported Apr 25
    		$1.42$1.15+23.48%Beat-26.4%
    Dec 22
    Reported Feb 9
    		$1.96$1.23+59.35%Beat-27.4%
    Sep 22
    Reported Oct 20
    		$1.44$1.22+18.03%Beat-27.6%
    Jun 22
    Reported Jul 21
    		$1.50$0.80+87.50%Beat-5.7%
    Mar 22
    Reported Apr 20
    		$1.93$1.06+82.08%Beat+48.5%
    Dec 21
    Reported Feb 7
    		$2.70$1.49+81.21%Beat-42.8%
    Sep 21
    Reported Oct 20
    		$1.99$1.08+84.26%Beat+210.9%
    Jun 21
    Reported Jul 21
    		$1.59$1.07+48.60%Beat+26.2%
    Mar 21
    Reported Apr 20
    		$1.30$0.72+80.56%Beat+1.6%
    Dec 20
    Reported Feb 9
    		$4.72$1.81+160.77%Beat+376.8%
    Sep 20
    Reported Oct 20
    		$0.64$0.24+166.67%Beat+10.3%
    Jun 20
    Reported Aug 3
    		$1.26$-0.71+277.46%Beat+125.0%
    Mar 20
    Reported May 4
    		$1.28$0.37+245.95%Beat+137.0%
    Dec 19
    Reported Feb 24
    		$0.99$0.98+1.02%Beat+94.1%
    Sep 19
    Reported Nov 4
    		$0.58$0.32+81.25%Beat+100.0%
    Jun 19
    Reported Aug 5
    		$0.56$0.44+27.27%Beat+14.3%
    Mar 19
    Reported Apr 29
    		$0.54$0.29+86.21%Beat-5.3%
    Dec 18
    Reported Feb 25
    		$0.51$0.28+82.14%Beat-63.6%
    Sep 18
    Reported Nov 5
    		$0.29$0.12+141.67%Beat+270.6%
    Jun 18
    Reported Aug 6
    		$0.49$0.23+113.04%Beat+388.2%
    Mar 18
    Reported Apr 30
    		$0.57$-0.04+1525.00%Beat+311.1%
    Dec 17
    Reported Feb 26
    		$1.40$1.24+12.90%Beat+2233.3%
    Sep 17
    Reported Oct 27
    		$-0.17N/A+60.47%Beat-
    Jun 17
    Reported Aug 7
    		$-0.17$-0.18+5.56%Beat-
    Mar 17
    Reported May 1
    		$-0.27$-0.52+48.08%Beat-
    Dec 16
    Reported Feb 27
    		$0.06N/A-72.73%Miss-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio13.80EV/EBITDA5.95x
    Price/FCF7.37xFCF Yield13.56%
    Profitability
    Profit Margin10.30%Operating Margin18.20%
    ROE37.30%ROIC21.50%
    Financial Health
    Debt/Equity2.84xInterest Coverage5.69x
    Current Ratio1.41xQuick Ratio1.35x
    Trading Statistics
    Beta1.20Avg Volume696.30K
    52-Week High$283.0552-Week Low$157.58

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$260.59
    SMA 20$259.99
    SMA 50$263.40
    SMA 200$215.77
    EMA 10$262.38
    EMA 20$261.24
    EMA 50$254.51
    EMA 200$221.33

    MACD

    Line: 1.30Signal: 0.36Hist: 0.94

    ADX

    ADX: 12.9+DI: 20.1-DI: 16.0

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down52.0
    PSAR$251.87

    Bollinger Bands

    Upper Band$268.91
    Lower Band$251.07
    %B Position686%(Upper)
    Band Width0.89

    RSI (14-Day)

    Neutral
    58.1

    Momentum Oscillators

    Stoch %K88.7
    Stoch %D82.1
    Williams %R-14.9
    ROC (10d)3.6%
    Momentum9.31
    CCI (20d)158.0
    MFI (14d)53.4

    Volatility Measures

    ATR (14d)$6.95(2.6%)
    StdDev (20d)4.46
    Hist Vol24.5%(Moderate)

    Volume Flow

    VWAP$267.22
    OBV59.2M
    AD Line31.7M
    CMF (20d)-0.164

    Volume Metrics

    Avg Vol (20d)708.7K
    Vol Ratio0.8x
    VWMA (20d)$260.47

    Pivot Points

    R3$276.86
    R2$273.47
    R1$271.11
    Pivot Point$267.72
    S1$265.36
    S2$261.97
    S3$259.61

    Advanced Oscillators

    TSI5.16
    Ultimate Osc47.1
    KST-20.01

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$5.63B$5.37B$5.53B$5.29B$5.27B$5.22B$5.07B$5.13B$5.11B$5.37B$5.38B$5.07B
    Cost of Revenue$2.23B$2.17B$2.22B$2.20B$2.16B$2.12B$2.09B$2.22B$2.17B$2.32B$533.00M$2.29B
    Gross Profit$3.40B$3.19B$3.31B$3.08B$3.11B$3.10B$2.98B$2.91B$2.94B$3.05B$4.85B$2.78B
    Operating Expenses$1.90B$1.90B$2.45B$2.20B$2.29B$2.16B$2.15B$1.82B$2.18B$-234,000,000$4.06B$2.21B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$2.16B$2.08B$0$2.05B$2.05B$2.00B$2.01B$1.99B$2.06B$2.08B$0$0
    Operating Income$1.50B$1.30B$853.00M$889.00M$823.00M$943.00M$821.00M$1.09B$761.00M$3.29B$789.00M$568.00M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$204.00M$205.00M$209.00M$206.00M$206.00M$204.00M$203.00M$202.00M$203.00M$226.00M$227.00M$227.00M
    Income Before Tax$1.34B$1.13B$681.00M$712.00M$642.00M$765.00M$655.00M$922.00M$587.00M$3.08B$519.00M$345.00M
    Income Tax Expense$295.00M$226.00M$37.00M$133.00M$120.00M$143.00M$83.00M$241.00M$110.00M$750.00M$63.00M$79.00M
    Net Income$1.04B$906.00M$644.00M$579.00M$522.00M$622.00M$572.00M$681.00M$477.00M$2.33B$456.00M$266.00M
    EBITDA$1.76B$1.57B$1.13B$1.14B$1.06B$1.18B$1.06B$1.34B$1.00B$3.53B$1.02B$803.00M
    EBIT$1.54B$1.34B$890.00M$918.00M$848.00M$969.00M$858.00M$1.12B$790.00M$3.31B$800.00M$572.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about THC

    Government Contracts

    Gov Obligations (TTM)
    $697716
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    5
    New Awards (TTM)
    3
    Avg Remaining Term
    3.3 mo

    Top agency: Department of Veterans Affairs at 51.6% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    W81K0026PA046Department of DefenseDepartment of the Army$349756Mar 1, 2026
    36C25726N0380Department of Veterans AffairsDepartment of Veterans Affairs$135000Aug 12, 2026
    36C25726N0207Department of Veterans AffairsDepartment of Veterans Affairs$135000Feb 12, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Argus raises target to USD 284 for Tenet Healthcare stock

    Argus has raised its price target for Tenet Healthcare (THC) to $284 following the company's strong second-quarter 2026 results. The healthcare provider reported $5.60 billion in revenue and adjusted EBITDA of $1.304...

    ad-hoc-news.de•10/15/26•Bullish

    Tenet Healthcare Corporation (THC) Stock Price, News, Quote & History

    This Yahoo Finance page provides comprehensive information on Tenet Healthcare Corporation (THC), including its current stock price, historical data...

    Yahoo! Finance Canada•10/14/26•Somewhat-Bullish

    Tenet Healthcare (THC) Draws A Higher Price Target, Is It Fully Priced?

    Argus recently raised its price target for Tenet Healthcare (THC) to US$284, drawing attention to the company's valuation. While the stock has seen strong momentum with a 38.77% 90-day return...

    Simply Wall Street•10/14/26•Neutral

    US88033GDU13 Bond Yield and Price — BONDSCOM:US88033GDU13

    This page provides detailed information on the Tenet Healthcare Corporation 6.75% 15-MAY-2031 bond, identified by ISIN US88033GDU13. It includes key terms such as outstanding amount, face value, coupon rate...

    TradingView•10/8/26•Neutral

    Tenet Healthcare (NYSE:THC): A Decent Value Stock Trading at a Discount

    Tenet Healthcare (NYSE:THC) is identified as a decent value stock trading at a discount, fitting a framework that seeks profitability, financial health, and growth. The company scores high in valuation and profitability...

    ChartMill•10/6/26•Bullish

    THC Valuation and Fair Value

    P/E
    13.8x
    Forward P/E
    12.5x
    EV/EBITDA
    6.0x
    P/FCF
    7.4x
    PEG
    1.8x
    P/B
    4.8x
    See GNG's fair value

    THC Profitability: Margins, ROIC and FCF

    Gross margin
    59.5%
    Operating margin
    18.2%
    Net margin
    10.3%
    ROIC
    21.5%
    ROE
    37.3%
    FCF margin
    13.9%
    FCF yield
    13.6%

    THC Competitors

    CompanyTicker
    Incyte CorporationINCY
    Insmed IncINSM
    Genmab ASGMAB
    STERIS plcSTE
    United Therapeutics CorporationUTHR
    Viatris IncVTRS
    Koninklijke Philips NV ADRPHG
    EXACT Sciences CorporationEXAS

    Sector: Healthcare

    THC Analyst Ratings

    Consensus
    Buy
    Analysts
    23
    Strong Buy
    5
    Buy
    14
    Hold
    4
    Sell
    0
    Strong Sell
    0

    THC Bull Case vs Bear Case

    Bull case

    • THC earns a 21.5% return on invested capital.
    • THC beat EPS estimates in 100.0% of its last 8 reported quarters.
    • 82.6% of THC's analyst ratings are Buy or Strong Buy.

    Bear case

    • THC has a debt-to-equity ratio of 2.8x.

    THC Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    27.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $4.67
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 1 down

    THC Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About THC

    Does THC pay dividends?

    Tenet Healthcare Corporation (THC) has a dividend payment track record. See the THC dividend history page for its current payment status, TTM yield, and recorded payments.

    What is THC's P/E ratio?

    Tenet Healthcare Corporation has a price-to-earnings (P/E) ratio of 13.80.

    What is THC's market cap?

    Tenet Healthcare Corporation (THC) has a market capitalization of $21.87B with a current stock price of $266.91.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In